Professor and Past-Chair, Department of Surgical Oncology
The University of Texas MD Anderson Cancer Center
Houston, Texas, United States
Dr. Charles M. Balch has led a distinguished career as a clinical and academic surgical oncologist for the past 48 years, as a leading authority in both melanoma and breast cancer. He has also made significant contributions to laboratory research in tumor immunology and human T lymphocyte differentiation. He is author of over 840 publications, which have been cited over 35,000 times in the biomedical literature (an average of 75 citations per article, h-index of 89). He has lectured in over 42 different countries in the world and most of the major academic centers in the United States. Dr Balch was the founding Editor-in-Chief of the Annals of Surgical Oncology, which is recognized as the leading journal in the world in its field, with over 11,000 surgical and library subscribers in 110 countries. He is also the Editor-in-Chief for Patient Resource Cancer Guides, which distribute nearly one million cancer guides (with 51 different titles) to cancer patients each year.
In past years, Dr. Balch has served as Executive Vice President and CEO of the American Society of Clinical Oncology (2000-2005), and as President and CEO of the City of Hope National Medical Center (1996-2000). At the University of Texas M.D. Anderson Cancer Center, from 1985-1996, Dr. Balch served as Executive Vice President for Health Affairs, Vice President of Hospital and Clinics, and Head of the Division of Surgery, among other positions. Dr. Balch’s leadership roles have involved the Society of Surgical Oncology (as President in 1992), where he currently serves as Editor-in-Chief Emeritus or the society’s peer-reviewed journal, the Annals of Surgical Oncology, the American Board of Surgery (Board of Directors), the Association of Academic Surgeons (President), The International Sentinel Node Society (as President), the Commission on Cancer (Chair, Board of Directors) and American Joint Committee on Cancer (Executive Committee).
Policies and Call for Action: Research
Thursday, March 21, 2024
10:45am – 10:50am ET